J1302 HCPCS code: Injection, sutimlimab-jome, 10 mg
J1302 is the HCPCS Level II code for injection, sutimlimab-jome, 10 mg. In 2024 Medicare paid an average of $13.98 per service for J1302 across 783,841 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 770 per day on DME suppliers. Medicare volume rose 1123% from 2022 to 2024 (64,091 to 783,841 services). In 2024, about 205 clinicians billed Medicare for J1302 for 78 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2022-10-01 |
| Last action effective | 2022-10-01 |
Who bills J1302 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 205 |
| Medicare beneficiaries | 78 |
| States with claims | 2 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1302, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 64,091 | 23 | $16.62 | $13.24 |
| 2023 | 519,000 | 54 | $17.19 | $13.70 |
| 2024 | 783,841 | 78 | $17.55 | $13.98 |
States with the most J1302 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 136,630 | $14.07 |
| Texas | 109,450 | $14.07 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 770 | Prescribing Information |
| outpatient hospital claims | 770 | Prescribing Information |
| practitioner claims | 770 | Prescribing Information |
What changed for J1302
- 2022-10-01: J1302 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1302?
J1302 is the HCPCS Level II code for injection, sutimlimab-jome, 10 mg. Short descriptor: "Inj, sutimlimab-jome, 10 mg".
How much does Medicare pay for J1302?
In 2024, the average Medicare payment was $13.98 per service (average allowed $17.55).
Does Medicare cover J1302?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1302 can be billed per day?
770 on DME suppliers; 770 on outpatient hospital claims; 770 on practitioner claims (NCCI medically unlikely edits).
Related J13 codes
- J1300 — Injection, eculizumab, 10 mg
- J1301 — Injection, edaravone, 1 mg
- J1303 — Injection, ravulizumab-cwvz, 10 mg
- J1304 — Injection, tofersen, 1 mg
- J1305 — Injection, evinacumab-dgnb, 5mg
- J1306 — Injection, inclisiran, 1 mg
- J1307 — Injection, crovalimab-akkz, 10 mg
- J1308 — Injection, famotidine, 0.25 mg
- J1320 — Injection, amitriptyline hcl, up to 20 mg
- J1322 — Injection, elosulfase alfa, 1 mg
- J1323 — Injection, elranatamab-bcmm, 1 mg
- J1324 — Injection, enfuvirtide, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1302
- Watch J1302 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1302
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.